The ACS Innovation Summit: Advancing Surgery Through Simulation, Technology, and Engineering offers valuable exposure to attendees, providing ample opportunities for one-on-one interactions with both current and potential customers. With a manageable size, the meeting encourages meaningful, in-depth conversations that are often difficult to achieve in overcrowded, competitive exhibit halls. This is an excellent opportunity to connect with decision-makers from academic teaching centers, medical schools, hospitals, and healthcare delivery systems who are responsible for purchasing your products and services.
Take advantage of this opportunity to engage with a diverse group of surgeons, physicians, educators, simulation center directors, administrators, technicians, and others from the U.S. and worldwide who are dedicated to educating learners, enhancing patient safety, and advancing the field of simulation-based surgical education. Attendees view the exhibits as an extension of their continuing education and are eager to learn from you about the latest advancements and trends in surgical simulation.
"Excellent meeting with highly qualified leads. We’ll be back next year!”
Please contact Dana McClure at dmcclure@facs.org with questions.
Dates: March 11–12, 2027
Location: Swissotel, Chicago, IL
Expected Number of Attendees: 300
MD/DO: 51%
Non-MD: 49%
United States: 92%
Canada: 2%
International: 6%
All levels exhibit at the ACS Innovation Summit. Choose one of the exhibit options below and reserve a space by February 12, 2027.
Please note: There are only 2 Platinum opportunities available.
Please Note:
REGISTRATION CONFIRMATION EMAIL AD | $500
Place your exclusive ad in the registration confirmation email sent to all attendees when they register for the meeting. This is an exclusive, high-visibility opportunity only granted to one exhibitor. Ad specs will be provided. The final ad is subject to review and approval by ACS.
Deadline: November 6, 2026
KNOW BEFORE YOU GO EMAIL AD | $500
Place your exclusive ad in the ‘Know Before You Go’ email sent to all attendees the week before the meeting with all the important information and final details they’ll need for the meeting. This is an exclusive, high-visibility opportunity only granted to one exhibitor! Ad specs will be provided. The final ad is subject to review and approval by ACS.
Deadline: February 12, 2027
Meeting Venue
Swissôtel Chicago
323 E. Wacker Dr.
Chicago, IL 60601
Exhibit Hours
Wednesday, March 10, 2027
2:00–7:30 pm Exhibit Setup
Thursday, March 11, 2027
7:00–8:00 am Registration, Breakfast & Exhibits (Room - Zurich ABC)
9:30–10:00 am Break and Exhibits (Room - Zurich ABC)
12:00–1:00 pm Lunch and Exhibits (Room - Zurich ABC)
5:00–6:00 pm Networking Reception and Exhibits (Room - Zurich ABC)
Friday, March 12, 2027
7:00–8:00 am Networking Breakfast & Exhibits (Room - Zurich ABC)
10:00–10:30am Break and Exhibits (Room - Zurich ABC)
12:30–1:30 pm Lunch and Exhibits (Room - Zurich ABC)
Swissôtel Chicago
323 E. Wacker Dr.
Chicago, IL 60601
Exhibitors may reserve a room within our discounted room block at the Swissôtel Chicago.
Written notification of a space cancellation must be received by ACS on or before February 12, 2027, to be eligible for a refund. A $500 service charge will be assessed for each cancellation space. No refunds will be given after February 12, 2027.
The performance of this Agreement by either party is subject to acts of God, war, government regulation, disaster, fire, epidemic, threatened or imminent strikes, civil disorder, curtailment of transportation facilities, threats or terrorist attacks, or other similar occurrence beyond the control of the parties, making it illegal, impossible, or commercially impractical to carry on the Summit or fully perform the terms of this Agreement. This Agreement may be terminated, or performance may be excused without penalty, for any one or more of such reasons by written notice from one party to the other.
Exhibitors must abide by all applicable Food and Drug Administration (FDA) regulations, including but not limited to any or all approved requirements. Exhibitors are reminded that the FDA prohibits the advertising or other promotion of investigational or unapproved drugs and devices and forbids the promotion of approved drugs or devices for unapproved uses. For additional information, contact FDA at 888-463-6332 or fda.gov.